Pharmacologic therapy for the neurogenic bladder.
This article is a review of the current and past literature on medical management of the neurogenic bladder, with a particular focus on spinal cord injury and multiple sclerosis. The use of antimuscarinics, αα-blocker, and tricyclic antidepressants and their combined use are discussed along with new therapies in human and animal trials.
Department of Urology, University of Michigan, 3875 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5330, USA. annepell@med.umich.edu
Anne P
AP
Cameron
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D018680:Cholinergic Antagonists / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006801:Humans; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D018680:Cholinergic Antagonists